Neurology

In this video, Paul B. Rosenberg, MD, discusses his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. The study found that dronabinol...

In this video, Kasia Rothenberg, MD, PhD, describes Alzheimer disease-related agitation, details the difficulty in testing for Alzheimer disease-related agitation, looks ahead to potential treatment options...

In this video, Alex Martinez discusses research on the use of human milk oligosaccharides (HMOs) in the prevention and treatment of nervous system diseases, such as Alzheimer disease, including the...

In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...

In a long-term follow-up study, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, and colleagues investigated how the quantity and quality of cardiovascular fat in women with Alzheimer disease measured during...

In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...

In this video, Gautam Dantas, PhD, discusses how the results of his study showed that altered gut bacteria may be an indicator of the earliest stages of Alzheimer disease.

In this video, Gillian T. Coughlan, MS, PhD discusses her team's study results, which found that female sex, early-age menopause, and hormone therapy use beginning more than 5 years after menopause were...

In this video, Paul Schulz, MD, discusses the next steps for research on the relationship between infection and Alzheimer disease. This is part three in a three-part series.

Early adulthood hypertension or increased blood pressure is associated with negative brain changes later in life including lower regional brain volumes and worse white matter integrity, factors that are...